Arvee Laboratories

Biotechnology & Medical Research
₹198.40
-4.15%
Prev close ₹207
Get AI-Powered Analysis for Arvee Laboratories Free Analysis → FREE View live price, charts & full analysis for Arvee Laboratories →

Arvee Laboratories Share Price Chart

Arvee Laboratories last traded at ₹198.40 (2026-10-13). Over the past month the stock moved +1.6%, three months the stock moved +24.5%, year the stock moved +12.1%. Its closing range over 52 weeks is ₹134.20 – ₹290.78, with the latest close 31.8% below the high.

Closing prices up to 2026-10-13.

About Arvee Laboratories

Incorporated in 2012, Arvee Laboratories India Ltd manufactures specialized chemicals[1]

Product Profile: a) Polymer Modifiers:[1] Dimethyl 5-Sodiosulfoisophthalate, 5-Sulfoisophthalic Acid Mono Sodium Salt, 5-Sulfoisophthalic Acid Mono Lithium Salt, 5-Sodiosulfo-Bis-(β-Hydroxyethyl)-Isophthalate b) Contrast Media Intermediates:[2] 5-Nitroisophthalic acid, Dimethyl 5-Nitroisophthalate, Monomethyl 5-Nitroisophthalate, 5-Hydroxyisophthalic acid, 5-Aminoisophthalic acid, Dimethyl 5-Aminoisophthalate, 3,5-Dinitrobenzoic Acid, 3,5-Diamino Benzoic Acid c) Drug Intermediates:[3] 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde, Amino Pyridine, Chloro Nitrobenzoic Acid

Fundamentals

Market Cap₹260.15 Cr
52W High₹315
52W Low₹18.80
P/E Ratio64.15
P/B Ratio7.33
EPS₹3.68
Dividend Yield0%
ROE (3yr)6%
Sales Growth (3yr)-20%
Profit Growth (3yr)-15%

Quarterly Results

In the latest quarter (Jun 2026), Arvee Laboratories reported sales of ₹17.23 crore (+130.3%) and net profit of ₹1.69 crore (+894.1%), compared with the same quarter last year.

Arvee Laboratories quarterly results (₹ crore)
PeriodSalesOperating profitOPM %Net profitEPS (₹)
Jun 202617.232.4914.451.691.53
Mar 202610.801.1010.190.520.47
Dec 20259.781.6316.671.831.66
Sep 20253.450.123.480.010.01
Jun 20257.480.344.550.170.15
Mar 20256.450.223.410.070.06
Dec 20248.910.343.820.150.14
Sep 202412.531.5011.970.980.89
Year-on-year change vs the same quarter last year
Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales growth+40.6%+15.7%+5.0%-29.4%-72.5%+9.8%+67.4%+130.3%
Operating profit growth+117.4%-35.8%-72.2%-77.9%-92.0%+379.4%+400.0%+632.4%
Net profit growth+366.7%-37.5%-41.7%-81.9%-99.0%+1120.0%+642.9%+894.1%
EPS growth+368.4%-36.4%-45.5%-82.4%-98.9%+1085.7%+683.3%+920.0%
OPM %12.0%3.8%3.4%4.6%3.5%16.7%10.2%14.5%

Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.

Annual Financials

In the latest year (Mar 2026), Arvee Laboratories reported sales of ₹31.51 crore (-18.1%) and net profit of ₹2.53 crore (+17.7%), compared with the previous year.

Arvee Laboratories annual profit & loss (₹ crore)
PeriodSalesOperating profitOPM %Net profitEPS (₹)
Mar 202631.513.1910.122.532.30
Mar 202538.493.619.382.151.95
Mar 202430.352.949.691.050.95
Mar 202361.357.2911.884.123.74
Mar 202240.335.6814.082.572.33
Mar 202147.386.0712.812.682.43
Mar 202045.426.0213.252.302.09
Mar 201954.906.1711.242.262.05
Year-on-year change vs the previous year
Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales growth+14.9%-17.3%+4.3%-14.9%+52.1%-50.5%+26.8%-18.1%
Operating profit growth-13.9%-2.4%+0.8%-6.4%+28.3%-59.7%+22.8%-11.6%
Net profit growth+107.3%+1.8%+16.5%-4.1%+60.3%-74.5%+104.8%+17.7%
EPS growth+107.1%+2.0%+16.3%-4.1%+60.5%-74.6%+105.3%+17.9%
OPM %11.2%13.3%12.8%14.1%11.9%9.7%9.4%10.1%

Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.

Shareholding

Promoter Holding73.50%

AI Analysis

No AI analysis generated yet for Arvee Laboratories.

Get Free AI Stock Analysis FREE →

Latest News

Frequently Asked Questions

What is Arvee Laboratories's current stock price?

Arvee Laboratories shares were last quoted at ₹198.40 (-4.2% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.

What is the P/E ratio of Arvee Laboratories?

Arvee Laboratories has a price-to-earnings (P/E) ratio of 64.15 and a price-to-book (P/B) ratio of 7.33. The industry P/E is 61.83.

What is the 52-week high and low of Arvee Laboratories?

The 52-week high of Arvee Laboratories is ₹315.00 and the 52-week low is ₹18.80.

What is the market cap of Arvee Laboratories?

The market capitalisation of Arvee Laboratories is about ₹260.15 crore.

How did Arvee Laboratories perform in its latest quarterly results?

In the latest quarter (Jun 2026), Arvee Laboratories reported sales of ₹17.23 crore (+130.3%) and net profit of ₹1.69 crore (+894.1%), compared with the same quarter last year.

Is Arvee Laboratories a good stock to buy?

This page is for information and is not investment advice. As per the data shown here, Arvee Laboratories has a 3-year ROE of 6.00%, 3-year profit growth of -15.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.

What is the promoter holding in Arvee Laboratories?

Promoters hold about 73.50% of Arvee Laboratories.

Which sector does Arvee Laboratories belong to?

Arvee Laboratories belongs to the Biotechnology & Medical Research sector.

Other Biotechnology & Medical Research stocks

All Biotechnology & Medical Research stocks · Browse all stocks A–Z

Go to live page for Arvee Laboratories →